Consolidated Statements of Operations |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
$ / shares
shares
|
Mar. 31, 2026
USD ($)
$ / shares
shares
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Mar. 31, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2026
USD ($)
$ / shares
shares
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
|||||||
| Revenues: | ||||||||||||||
| Total revenues | $ 336,000 | $ 1,114,000 | $ 747,000 | $ 43,000 | ||||||||||
| Operating expenses | ||||||||||||||
| Cost of sales | 257,000 | 892,000 | 609,000 | |||||||||||
| Research and development | 848,000 | 6,655,000 | ||||||||||||
| General and administrative expenses | 497,000 | 1,249,000 | 886,000 | 5,463,000 | 7,717,000 | 5,392,000 | ||||||||
| Total operating expenses | 754,000 | 1,249,000 | 1,778,000 | 5,463,000 | 9,174,000 | 12,047,000 | ||||||||
| Operating loss from continuing operations | (418,000) | (1,249,000) | (664,000) | (5,463,000) | (8,427,000) | (12,004,000) | ||||||||
| Other income | ||||||||||||||
| Foreign exchange gains (losses) | (18,000) | (3,000) | 21,000 | (11,000) | 73,000 | (54,000) | ||||||||
| Interest income | 9,000 | 2,000 | 18,000 | 8,000 | 62,000 | 12,000 | ||||||||
| Gain on deconsolidation of former subsidiary | 4,947,000 | |||||||||||||
| Other income, net | 31,000 | 2,000 | 62,000 | 12,000 | 354,000 | 52,000 | ||||||||
| Total other income, net | 22,000 | 1,000 | 101,000 | 9,000 | 5,436,000 | 10,000 | ||||||||
| Income / (loss) before income taxes | (396,000) | (1,248,000) | (563,000) | (5,454,000) | (2,991,000) | (11,994,000) | ||||||||
| Income tax provision | (9,000) | (2,000) | (39,000) | (2,000) | (7,000) | 782,000 | ||||||||
| Net income / (loss) from continuing operations | (405,000) | (1,250,000) | (602,000) | (5,456,000) | ||||||||||
| DISCONTINUED OPERATIONS | ||||||||||||||
| Operating losses from discontinued operations | (68,000) | (890,000) | ||||||||||||
| Gain on deconsolidation of subsidiary | 4,947,000 | |||||||||||||
| Net income from discontinued operations, net of tax | (68,000) | 4,057,000 | ||||||||||||
| NET INCOME (LOSS) | (405,000) | $ (197,000) | (1,318,000) | $ (81,000) | (602,000) | (1,399,000) | (2,998,000) | (11,212,000) | ||||||
| OTHER COMPREHENSIVE INCOME (LOSS) | ||||||||||||||
| Foreign currency translation adjustments | 30,000 | 39,000 | 3,271,000 | 2,346,000 | 2,916,000 | |||||||||
| Total comprehensive income | (375,000) | (1,318,000) | (563,000) | (508,000) | (3,032,000) | (11,195,000) | ||||||||
| Dividend on convertible exchangeable preferred shares | (20,000) | (20,000) | (40,000) | (20,000) | (61,000) | |||||||||
| Deemed dividend on warrant exchange | (11,033,000) | |||||||||||||
| Net loss applicable to common shareholders | $ (425,000) | $ (1,338,000) | $ (642,000) | $ (1,419,000) | $ (14,092,000) | $ (11,212,000) | ||||||||
| EARNINGS PER SHARE — basic and diluted* | ||||||||||||||
| EARNINGS (LOSS) PER SHARE - Basic | $ / shares | $ (6.45) | $ (502.46) | ||||||||||||
| EARNINGS (LOSS) PER SHARE - Diluted | $ / shares | $ (6.45) | $ (502.46) | ||||||||||||
| Continuing operations Basic (USD per share) | $ / shares | $ (0.08) | $ (0.93) | $ (0.12) | $ (1.62) | ||||||||||
| Continuing operations Diluted (USD per share) | $ / shares | (0.08) | (0.93) | (0.12) | (1.62) | ||||||||||
| Discontinued operations Basic (USD per share) | $ / shares | (0.05) | 4.62 | ||||||||||||
| Discontinued operations Diluted (USD per share) | $ / shares | $ (0.05) | $ 4.62 | ||||||||||||
| Weighted average shares outstanding - Basic | shares | 5,598,701 | 1,360,626 | 5,568,424 | 878,095 | 2,185,075 | 22,314 | ||||||||
| Weighted average shares outstanding - Diluted | shares | 5,598,701 | 1,360,626 | 5,568,424 | 878,095 | 2,185,075 | 22,314 | ||||||||
| Future NRG Sdn. Bhd. [Member] | ||||||||||||||
| Revenues: | ||||||||||||||
| Total revenues | 183,976 | 203,630 | $ 373,123 | $ 421,912 | $ 854,337 | $ 871,741 | ||||||||
| Cost of revenues | ||||||||||||||
| Total cost of revenues | (137,688) | (126,884) | (259,986) | (256,900) | (580,357) | (598,307) | ||||||||
| Gross profit | 46,288 | 76,746 | 113,137 | 165,012 | 273,980 | 273,434 | ||||||||
| Operating expenses | ||||||||||||||
| General and administrative expenses | 13,406 | 9,292 | 23,544 | 19,101 | 35,708 | 114,979 | ||||||||
| Selling and distribution costs | (324) | (408) | (24,832) | (803) | (5,907) | (8,669) | ||||||||
| Loss on disposal of equity interest in subsidiary | (1,919,251) | (1,904,424) | ||||||||||||
| Compensation and benefits | (28,433) | (23,919) | (55,104) | (50,839) | (97,826) | (86,105) | ||||||||
| Depreciation and amortization | (48,114) | (44,090) | (96,504) | (92,277) | (191,982) | (173,709) | ||||||||
| Professional fees | (24,157) | (63) | (45,030) | (345) | (14,480) | (16,595) | ||||||||
| Impairment on financial assets / ECL | 2,452 | (35,616) | (32,318) | |||||||||||
| Total operating expenses | 2,033,685 | 77,772 | 2,146,986 | 163,365 | 381,519 | 432,375 | ||||||||
| Operating loss from continuing operations | (1,987,397) | (1,026) | (2,033,849) | 1,647 | (107,539) | (158,941) | ||||||||
| Other income | ||||||||||||||
| Interest income | 40,677 | 35,508 | ||||||||||||
| Total other income, net | 1,941,507 | 1,926,508 | ||||||||||||
| Income / (loss) before income taxes | (45,890) | (1,026) | (107,341) | 1,647 | (66,862) | (123,433) | ||||||||
| Income tax provision | (278) | |||||||||||||
| Net income / (loss) from continuing operations | (45,890) | (1,026) | (107,341) | 1,647 | (67,140) | (123,433) | ||||||||
| DISCONTINUED OPERATIONS | ||||||||||||||
| Net income from discontinued operations, net of tax | 2,557,550 | 921,119 | ||||||||||||
| NET INCOME (LOSS) | (45,890) | (1,026) | (107,341) | 1,647 | 2,490,410 | 797,686 | ||||||||
| OTHER COMPREHENSIVE INCOME (LOSS) | ||||||||||||||
| Foreign currency translation adjustments | (28,493) | (119,311) | (96,372) | (137,614) | 174,075 | 22,645 | ||||||||
| Total comprehensive income | $ (74,383) | $ (120,337) | $ (203,713) | $ (135,967) | $ 2,664,485 | $ 820,331 | ||||||||
| EARNINGS PER SHARE — basic and diluted* | ||||||||||||||
| EARNINGS (LOSS) PER SHARE - Basic | $ / shares | $ 0.0889 | $ 0.0285 | ||||||||||||
| EARNINGS (LOSS) PER SHARE - Diluted | $ / shares | 0.0889 | 0.0285 | ||||||||||||
| Continuing operations Basic (USD per share) | $ / shares | $ (0.0016) | [1] | $ (0.0000) | [1] | $ (0.0038) | [1] | $ 0.0001 | [1] | (0.0024) | (0.0044) | ||||
| Continuing operations Diluted (USD per share) | $ / shares | (0.0016) | [1] | (0.0000) | [1] | (0.0038) | [1] | 0.0001 | [1] | (0.0024) | (0.0044) | ||||
| Discontinued operations Basic (USD per share) | $ / shares | [1] | [1] | [1] | [1] | 0.0913 | 0.0329 | ||||||||
| Discontinued operations Diluted (USD per share) | $ / shares | [1] | [1] | [1] | [1] | $ 0.0913 | $ 0.0329 | ||||||||
| Weighted average shares outstanding - Basic | shares | 28,000,000 | [1] | 28,000,000 | [1] | 28,000,000 | [1] | 28,000,000 | [1] | 28,000,000 | 28,000,000 | ||||
| Weighted average shares outstanding - Diluted | shares | 28,000,000 | [1] | 28,000,000 | [1] | 28,000,000 | [1] | 28,000,000 | [1] | 28,000,000 | 28,000,000 | ||||
| Product Revenue Fire Safety [Member] | ||||||||||||||
| Revenues: | ||||||||||||||
| Total revenues | $ 747,000 | |||||||||||||
| Clinical Trial Supply [Member] | ||||||||||||||
| Revenues: | ||||||||||||||
| Total revenues | 43,000 | |||||||||||||
| Compensation and Benefits [Member] | Future NRG Sdn. Bhd. [Member] | ||||||||||||||
| Cost of revenues | ||||||||||||||
| Total cost of revenues | $ (20,691) | $ (15,640) | $ (39,753) | $ (32,655) | (72,663) | (83,223) | ||||||||
| Upkeep of Plant [Member] | Future NRG Sdn. Bhd. [Member] | ||||||||||||||
| Cost of revenues | ||||||||||||||
| Total cost of revenues | (86,163) | (81,852) | (169,126) | (159,072) | (345,172) | (371,934) | ||||||||
| Other Cost Of Revenues [Member] | Future NRG Sdn. Bhd. [Member] | ||||||||||||||
| Cost of revenues | ||||||||||||||
| Total cost of revenues | (30,834) | (29,392) | (51,107) | (65,173) | $ (162,522) | $ (143,150) | ||||||||
| Revenue from Services [Member] | Future NRG Sdn. Bhd. [Member] | ||||||||||||||
| Revenues: | ||||||||||||||
| Total revenues | $ 183,976 | $ 203,630 | $ 373,123 | $ 421,912 | ||||||||||
| ||||||||||||||
| X | ||||||||||
- Definition Cost of sales No definition available.
|
| X | ||||||||||
- Definition Deemed dividend on warrant exchange No definition available.
|
| X | ||||||||||
- Definition Gain on deconsolidation of subsidiary No definition available.
|
| X | ||||||||||
- Definition Loss on disposal of equity interest in subsidiary. No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss for asset. Includes, but is not limited to, tangible and intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|